Why Novo Holdings Has Invested In ‘Hidden Gem’ Oxford Biomedica

 
• By Sten Stovall

Life sciences investor Novo Holdings buys 10% stake in UK gene therapy biotech.

Money_Plants
Novo Holdings is investing £53.5m in Oxford Biomedica • Source: Shutterstock

More from Deals

More from Business